Ligand Pharmaceuticals Inc (LGND)
116.89
+5.33
(+4.78%)
USD |
NASDAQ |
Nov 21, 16:00
116.89
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap: 2.209B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.108B |
| November 19, 2024 | 2.113B |
| November 18, 2024 | 2.110B |
| November 15, 2024 | 2.111B |
| November 14, 2024 | 2.181B |
| November 13, 2024 | 2.307B |
| November 12, 2024 | 2.281B |
| November 11, 2024 | 2.333B |
| November 08, 2024 | 2.291B |
| November 07, 2024 | 2.455B |
| November 06, 2024 | 2.209B |
| November 05, 2024 | 2.100B |
| November 04, 2024 | 2.068B |
| November 01, 2024 | 2.064B |
| October 31, 2024 | 1.983B |
| October 30, 2024 | 2.060B |
| October 29, 2024 | 2.167B |
| October 28, 2024 | 2.127B |
| October 25, 2024 | 2.098B |
| October 24, 2024 | 2.082B |
| October 23, 2024 | 2.005B |
| October 22, 2024 | 1.998B |
| October 21, 2024 | 2.003B |
| October 18, 2024 | 1.996B |
| October 17, 2024 | 1.986B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.010B |
| October 15, 2024 | 1.958B |
| October 14, 2024 | 1.941B |
| October 11, 2024 | 1.931B |
| October 10, 2024 | 1.882B |
| October 09, 2024 | 1.937B |
| October 08, 2024 | 1.932B |
| October 07, 2024 | 1.925B |
| October 04, 2024 | 1.966B |
| October 03, 2024 | 1.918B |
| October 02, 2024 | 1.875B |
| October 01, 2024 | 1.901B |
| September 30, 2024 | 1.878B |
| September 27, 2024 | 1.779B |
| September 26, 2024 | 1.816B |
| September 25, 2024 | 1.805B |
| September 24, 2024 | 1.818B |
| September 23, 2024 | 1.821B |
| September 20, 2024 | 1.878B |
| September 19, 2024 | 1.918B |
| September 18, 2024 | 1.894B |
| September 17, 2024 | 1.905B |
| September 16, 2024 | 1.918B |
| September 13, 2024 | 1.914B |
| September 12, 2024 | 1.865B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
674.93M
Minimum
Mar 16 2020
2.455B
Maximum
Nov 07 2024
1.272B
Average
1.221B
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 81.80B |
| Agios Pharmaceuticals Inc | 3.168B |
| ADMA Biologics Inc | 5.034B |
| Pieris Pharmaceuticals Inc | 21.03M |
| AnaptysBio Inc | 644.63M |
Market Cap Related Metrics
| PE Ratio | 46.57 |
| PS Ratio | 13.85 |
| PEG Ratio | 0.2301 |
| Price to Book Value | 2.626 |
| Price to Free Cash Flow | 302.98 |
| Price | 116.89 |
| Earnings Yield | 2.15% |
| PEGY Ratio | 0.2301 |
| Operating PE Ratio | 117.44 |